AstraZeneca PLC
AZN · NASDAQ
9/30/2025 | 6/30/2025 | 3/30/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,533,000 | $3,127,000 | $2,916,000 | $1,666,000 |
| Dep. & Amort. | $1,549,000 | $1,389,000 | $1,284,000 | $714,000 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $835,000 | -$345,000 | -$426,000 | -$350,000 |
| Other Non-Cash | $217,000 | -$785,000 | -$61,000 | $877,000 |
| Operating Cash Flow | $5,134,000 | $3,386,000 | $3,713,000 | $2,907,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$686,000 | -$659,000 | -$429,000 | -$708,000 |
| Net Acquisitions | -$328,000 | -$267,000 | -$362,000 | -$274,000 |
| Inv. Purchases | $0 | -$188,000 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $114,000 | $0 | -$32,000 |
| Other Inv. Act. | -$987,000 | -$1,108,000 | -$462,000 | -$167,000 |
| Investing Cash Flow | -$2,001,000 | -$2,108,000 | -$1,253,000 | -$1,181,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$93,000 | $632,000 | $1,095,000 | -$608,000 |
| Stock Issued | $0 | $1,000 | -$478,000 | $23,000 |
| Stock Repurch. | -$19,000 | $0 | $0 | $0 |
| Dividends Paid | -$1,611,000 | -$10,000 | -$3,347,000 | -$3,000 |
| Other Fin. Act. | -$350,000 | -$105,000 | $23,000 | -$83,000 |
| Financing Cash Flow | -$2,073,000 | $518,000 | -$2,707,000 | -$671,000 |
| Forex Effect | -$12,000 | $29,000 | $25,000 | -$61,000 |
| Net Chg. in Cash | $1,048,000 | $1,825,000 | -$222,000 | $994,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $7,032,000 | $5,207,000 | $5,429,000 | $4,435,000 |
| End Cash | $8,080,000 | $7,032,000 | $5,207,000 | $5,429,000 |
| Free Cash Flow | $4,448,000 | $1,463,000 | $3,284,000 | $1,952,000 |